New Lifetime High Today: Mednax (MD)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Mednax ( MD) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Mednax as such a stock due to the following factors:

  • MD has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $46.4 million.
  • MD has traded 18,925 shares today.
  • MD is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in MD with the Ticky from Trade-Ideas. See the FREE profile for MD NOW at Trade-Ideas

More details on MD:

MEDNAX, Inc., together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the United States and Puerto Rico. MD has a PE ratio of 23. Currently there are 10 analysts that rate Mednax a buy, no analysts rate it a sell, and 3 rate it a hold.

The average volume for Mednax has been 519,700 shares per day over the past 30 days. Mednax has a market cap of $6.9 billion and is part of the health care sector and health services industry. The stock has a beta of 0.87 and a short float of 6.9% with 10.26 days to cover. Shares are up 11.5% year-to-date as of the close of trading on Tuesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Why the Boardroom Doesn't Need Ivy League Degrees

Mednax: Solid Growth at a Good Price

Analysts' Actions -- Kimberly-Clark, IberiaBank, Ionis Pharma, Actuant and More

How to Invest in Your Favorite MD